Thursday, February 5, 2009

Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market

Feb 5, 2009 - Dr. Reddy's Laboratories today announced that it has launched the following five products in the US market during the month of January:

Levetiracetam tablets (250mg, 500mg, 750mg & 1000mg
Omeprazole capsules (40mg
Lamotragine CD chewable tablets (5mg & 25mg)
Divalproex capsules & delayed release pellets (125mg)
Lamotrigine tablets (25mg, 100mg, 150mg & 200mg)

The details can be read here.

No comments: